The expression of p73 is increased in lung cancer, independent of p53 gene alteration

British Journal of Cancer

Volumn 80, Issue 10, 1999, Pages 1623-1629

  Tokuchi, Y ^a   Hashimoto, T ^a   Kobayashi, Y ^a   Hayashi, M ^a   Nishida, K ^a   Hayashi, S ^a   Imai, K ^a   Nakachi, K ^a   Ishikawa, Y ^b   Nakagawa, K ^b   Kawakami, Y ^c   Tsuchiya, E ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b CANCER INSTITUTE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

1p36; Lung cancer; p53; p73; Tumour suppressor gene

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BLOTTING, SOUTHERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 0032988708     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690572     Document Type: Article

References (23)

1. Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Delattre O and Versteeg R (1995) Evidence for two tumor suppressor loci on chromosomal bands Ip35-36 involved in neuroblastoma: one probably imprinted, another associated with N-mye amplification. Hum Mol Genet 4: 535-539
2. Chomczynski P and Sacchi N (1987) Single-step methods of isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem 162: 156-159
3. Dickman S (1997) First p53 relative may be a new tumor suppressor. Science 277: 1605-1606
4. Framer G, Bargonelti J, Zhu H, Freiedman P, Prywes R and Prives C (1992) Wild-type p53 activates transcription in vitro. Nature 358: 83-86
5. Jost CA, Martin MC and Kaelin WG Jr (1997) p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191-194
6. Kaghard M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias J M, Dumont X, Ferrara P, McKeon F and Caput D (1997) Monoallelically expressed gene related to p53 at Ip36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819
7. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkette BS, Vorgelstein B and Fornance AJ Jr (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in atalaxia-telangiectasia. Cell 71: 587-597
8. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B (1992) Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256: 827-830
9. Kishimoto Y, Murakami Y, Shiraishi M, Hayashi K and Sekiya T (1992) Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res 52: 4799-4804
10. Ko LJ and Privies C (1996) p53: puzzle and paradigm. Genes Dev 10. 1054-1072
11. Levine AJ (1997) p53, the cellular gate keeper for growth and division. Cell 88: 323-331
12. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tisty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935
13. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
14. Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI and Liu W (1998) Activation of p73 silent allele in lung cancer. Cancer Res 58: 2347-2349
15. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T, Takahashi T and Takahashi T (1998) Search for mutations and examination of allelic expression imbalance of the p73 gene at Ip36.33 in human lung cancers. Cancer Res 58: 1380-1383.
16. Oren M (1997) Lonely no more: p53 finds its kin in a tumor suppressor haven. Cell 90: 829-832.
17. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
18. Takahashi H, Ichimiya S, Nimura Y, Watanabe M, Furusato M, Wakui S, Yatani R, Aizawa S and Nakagawara A (1998) Mutation, allelotyping, and transcription analysis of the p73 gene in prostatic carcinoma. Cancer Res 58: 2076-2077.
19. Tokuchi Y, Kobayashi Y, Hayashi S, Hayashi M, Tanimoto K, Hashimoto T, Nishida K, Ishikawa Y, Nakagawa K, Satoh Y, Yamamoto M and Tsuchiya E (1999) Abnormal FHIT transcripts found in both lung cancer and normal lung tissue. Genes Chromosomes Cancer 24: 105-111
20. Tsuchiya E, Nakamura Y, Weng S-Y, Nakagawa K, Tsuchiya S, Sugano H and Kitagawa T (1992) Allelotype of non-small cell lung carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52: 2478-2481.
21. UICC (International Union Against Cancer) (1992) TNM Classification of Malignant Tumours, 4th Edn, Revision 2. Berlin; Springer-Verlag
22. World Health Organization (1981) Histological Typing of Lung Tumours. Geneva: World Health Organization.
23. Zambetti GP and Levine AJ (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB J 7: 855-865.